Sporegen Limited
Private Limited Company · London
ActiveUnited KingdomIncorporated 2012Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-03-31
IXBRL · 133 source facts · 23 selected values
Not assessedlegacy record
Accounts to 2025-03-31
IXBRL · 133 source facts · 23 selected values
Not assessed
legacy record
- Reporting period
- 2024-04-01 to 2025-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 79
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2508_08001035_20250331
- Source archive
- Accounts_Monthly_Data-August2025.zip
Accounts to 2024-03-31
IXBRL · 138 source facts · 27 selected values
Not assessedlegacy record
Accounts to 2024-03-31
IXBRL · 138 source facts · 27 selected values
Not assessed
legacy record
- Reporting period
- 2023-04-01 to 2024-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 83
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2266_08001035_20240331
- Source archive
- Accounts_Monthly_Data-June2024.zip
Accounts to 2023-03-31
IXBRL · 142 source facts · 27 selected values
Not assessedlegacy record
Accounts to 2023-03-31
IXBRL · 142 source facts · 27 selected values
Not assessed
legacy record
- Reporting period
- 2022-04-01 to 2023-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 90
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0029_08001035_20230331
- Source archive
- Accounts_Monthly_Data-October2023.zip
Accounts to 2022-03-31
IXBRL · 135 source facts · 27 selected values
Not assessedlegacy record
Accounts to 2022-03-31
IXBRL · 135 source facts · 27 selected values
Not assessed
legacy record
- Reporting period
- 2021-04-01 to 2022-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 84
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0002_08001035_20220331
- Source archive
- Accounts_Monthly_Data-December2022.zip
Accounts to 2021-03-31
IXBRL · 136 source facts · 27 selected values
Not assessedlegacy record
Accounts to 2021-03-31
IXBRL · 136 source facts · 27 selected values
Not assessed
legacy record
- Reporting period
- 2020-04-01 to 2021-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 85
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0096_08001035_20210331
- Source archive
- Accounts_Monthly_Data-November2021.zip
Accounts to 2020-03-31
IXBRL · 132 source facts · 21 selected values
Not assessedlegacy record
Accounts to 2020-03-31
IXBRL · 132 source facts · 21 selected values
Not assessed
legacy record
- Reporting period
- 2019-04-01 to 2020-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 80
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0081_08001035_20200331
- Source archive
- Accounts_Monthly_Data-August2020.zip
Accounts to 2019-03-31
IXBRL · 120 source facts · 19 selected values
Not assessedlegacy record
Accounts to 2019-03-31
IXBRL · 120 source facts · 19 selected values
Not assessed
legacy record
- Reporting period
- 2018-04-01 to 2019-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 70
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0071_08001035_20190331
- Source archive
- Accounts_Monthly_Data-October2019.zip
Accounts to 2018-03-31
IXBRL · 112 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2018-03-31
IXBRL · 112 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2017-04-01 to 2018-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 67
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0059_08001035_20180331
- Source archive
- Accounts_Monthly_Data-October2018.zip
Registered details
08001035- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2012-03-22
- Jurisdiction
- —
- Registered office
- 1THE LONDON BIOSCIENCE INNOVATION CENTRE, 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH, ENGLAND
Classification
1 SIC codes23103
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
3 matched grantsSPOR-COV: Prophylaxis of COVID-19 using Innate ImmunityLeadInnovate UK · Collaborative R&D · 2020-09-01 – 2022-10-31 · with 2 other participants£302,602awarded
SPOR-COV: Prophylaxis of COVID-19 using Innate ImmunityLead
Innovate UK · Collaborative R&D · 2020-09-01 – 2022-10-31 · with 2 other participants
£302,602
awarded
Definition and induction of broadly protective responses against HIV-1MRC · Research Grant · 2016-06-30 – 2022-03-30 · with 38 other participants£1,234,490whole project
Definition and induction of broadly protective responses against HIV-1
MRC · Research Grant · 2016-06-30 – 2022-03-30 · with 38 other participants
£1,234,490
whole project
University Of OxfordleadAdvent S.r.lAELIX TherapeuticsAIDS Clinical Trials Group (ACTG)Amsterdam Medical CenterBioNTech AGDuke University Medical CentreGeorge Washington UniversityGilead Sciences, Inc.Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF)Icahn School of Medicine at Mount SinaiIDT Biologika GmbHImperial College LondonInternational AIDS Vaccine Initiative (IAVI)Johns Hopkins UniversityKing'S College LondonLos Alamos National LaboratoryMedical Research Council (MRC)ModernaMRC/UVRI Uganda Research Unit on AIDSNational Institute for Biological Standards and Control (NIBSC)National Institutes of Health (NIH)Nouscom AGOregon Health and Science UniversityOxford BioMedica UK LtdPublic Health Agency of CanadaRoyal Holloway, University of LondonSporeGen LimitedUnited States Agency for International DevelopmentUniversity of BristolUniversity of GeorgiaUniversity of NairobiUniversity of North Carolina at Chapel HillUniversity of PennsylvaniaUniversity of PittsburghUniversity of PlymouthUniversity of StellenboschWalter Reed Army Institute of ResearchZambia Emory HIV Research Project
Scaling up ProductionLead
Innovate UK · Vouchers · 2015-08-01 – 2016-01-31
£5,000
awarded